Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin

Details for Australian Patent Application No. 2002365441 (hide)

Owner Biosynexus Incorporated

Inventors Kokai-Kun, John F; Mond, James J; Walsh, Scott M; Chanturiya, Tatyana Ivanovna

Agent Griffith Hack

Pub. Number AU-B-2002365441

PCT Number PCT/US02/40927

PCT Pub. Number WO2003/065980

Priority 60/341,802 21.12.01 US

Filing date 23 December 2002

Wipo publication date 2 September 2003

Acceptance publication date 28 February 2008

International Classifications

A61K 9/06 (2006.01) Medicinal preparations characterised by special physical form - Ointments

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/46 (2006.01) Medicinal preparations containing peptides

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61K 47/44 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Oils, fats or waxes according to more than one of groups

A61P 27/16 (2006.01) Drugs for disorders of the senses

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 60/341,802 21.12.01 US

25 September 2003 Application Open to Public Inspection

  Published as AU-B-2002365441

28 February 2008 Application Accepted

  Published as AU-B-2002365441

26 June 2008 Standard Patent Sealed

22 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002365442-METHOD OF INHIBITING PATHOGENICITY OF INFECTIOUS AGENTS

2002365440-METHODS FOR BLOCKING OR ALLEVIATING STAPHYLOCOCCAL NASAL COLONIZATION BY INTRANASAL APPLICATION OF MONOCLONAL ANTIBODIES